The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T-cell lymphoma (Q40715942)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 20 July 2015

Language	Label	Description	Also known as
English	The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T-cell lymphoma	scientific article published on 20 July 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T-cell lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Pier Luigi Zinzani

9

object named as

Pier L Zinzani

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

1

object named as

Enrica Marchi

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Owen A. O'Connor

14

object named as

Owen A O'Connor

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Stefano A Pileri

10

object named as

Stefano A Pileri

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

author name string

Kelly M Zullo

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Jennifer E Amengual

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Matko Kalac

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Danielle Bongero

5

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Christine M McIntosh

6

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Laura K Fogli

7

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Pier P Piccaluga

11

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Fabio Fuligni

12

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Luigi Scotto

13

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

language of work or name

0 references

publication date

20 July 2015

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sirtuin and pan-class I/II deacetylase (DAC) inhibition is synergistic in preclinical models and clinical studies of lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

Minimum information about a microarray experiment (MIAME)-toward standards for microarray data

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

Brentuximab vedotin

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

Evaluation of the long-term tolerability and clinical benefit of vorinostat in patients with advanced cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

Gene Expression Omnibus: NCBI gene expression and hybridization array data repository

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

Cluster analysis and display of genome-wide expression patterns

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

Identifying biological themes within lists of genes with EASE

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

A literature network of human genes for high-throughput analysis of gene expression

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

Pralatrexate is synergistic with the proteasome inhibitor bortezomib in in vitro and in vivo models of T-cell lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

Romidepsin and belinostat synergize the antineoplastic effect of bortezomib in mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

Linear models and empirical bayes methods for assessing differential expression in microarray experiments

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

The schedule-dependent effects of the novel antifolate pralatrexate and gemcitabine are superior to methotrexate and cytarabine in models of human non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

IMA: an R package for high-throughput analysis of Illumina's 450K Infinium methylation data

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

Targeted treatment and new agents in peripheral T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

Emerging role of epigenetic therapies in cutaneous T-cell lymphomas.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas

1 reference

https://api.crossref.org/works/10.1111%2FBJH.13566

21 January 2018

Identifiers

10.1111/BJH.13566

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40715942&oldid=1905109530"